Don't forget to nominate 2019's fiercest women in life sciences

Three people looking at a display of black and white photos depecting a diverse group of people
Your nominees may be industry professionals, academics, venture capitalists—any woman who's making a mark on the life sciences industry. (Gerd Altmann)

If you’ve been sitting on your nominations for this year’s Fiercest Women in Life Sciences, don’t wait too long! Now is the perfect time to submit them as nominations will close in two weeks.

To recap, we’re looking for women in biotech, pharma and medtech who, in spite of challenges both unique to the industry and to being female, stand out as leaders, innovators and mentors. They can be industry professionals, academics, venture capitalists—you name it.

We are often asked if we have a list of criteria for consideration. We don’t. If a particular woman is making a mark on the life sciences industry, we want to hear about her.


Use Serialization Data to Maximize Performance and Minimize Risks

Wednesday, March 18 | 11am ET / 8am PT

Serialized products generate a wealth of data as they move through the supply chain. What if you could access and analyze this data to gain operational visibility and powerful business insight? It’s time to put your serialization investment to work for you.

For a taste of what we’re looking for, check out last year's feature here and 2017’s here. Please submit your nominations using the form below. It will be open until 11:59 p.m. EDT on Monday, Aug. 19. 





Suggested Articles

Several of the industry's top players had a strong performance in the fourth quarter, growing revenues at high single digits. Others? Not so much.

Viatris, the merger of Mylan and Pfizer's Upjohn, has fleshed out its board and C-suite with a raft of Pfizer and Mylan veterans.

An FDA approval of Lilly’s Cyramza combo would pit it against AZ's Tagrisso, which has charted impressive survival gains in EGFR-positive lung cancer.